Get Our Top Trade Ideas Delivered Daily - 65% Off Now'
get this deal
España
India
Italia
대한민êµ
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
Get Our Top Trade Ideas Delivered Daily - 65% Off Now'
get this deal
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Acrivon Therapeutics
ACRV
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$9.49
-0.49
-4.91%
At Close: -
$9.98
0.49
5.16%
After Hours: Aug 29, 4:02 PM EDT
15 minutes delayed
Get Report
Comment
Acrivon Therapeutics (ACRV) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Acrivon Therapeutics (NASDAQ:ACRV) Stock
Acrivon Therapeutics Stock (NASDAQ: ACRV)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, August 13, 2024
HC Wainwright & Co. Reiterates Buy on Acrivon...
Benzinga Newsdesk
Acrivon Therapeutics Q2 EPS $(0.52) Beats $(0...
Benzinga Newsdesk
Wednesday, July 10, 2024
Athira Completes Dosing in Alzheimer's Study, Stock Up
Zacks
Thursday, June 27, 2024
Beam Therapeutics Begins Dosing in Phase I/II AATD Study
Zacks
Thursday, June 13, 2024
Ultragenyx Posts New Data From Bone Disease Study
Zacks
Wednesday, May 15, 2024
BMO Capital Reiterates Outperform on Acrivon ...
Benzinga Newsdesk
Tuesday, May 14, 2024
HC Wainwright & Co. Maintains Buy on Acrivon ...
Benzinga Newsdesk
Acrivon Therapeutics Q1 EPS $(0.73) Beats $(0...
Benzinga Newsdesk
Monday, April 29, 2024
Ladenburg Thalmann Downgrades Acrivon Therape...
Benzinga Newsdesk
Friday, April 26, 2024
BMO Capital Maintains Outperform on Acrivon T...
Benzinga Newsdesk
Thursday, April 25, 2024
JMP Securities Maintains Market Outperform on...
Benzinga Newsdesk
Piper Sandler Maintains Overweight on Acrivon...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Acrivon...
Benzinga Newsdesk
Acrivon Therapeutics shares are trading highe...
Benzinga Newsdesk
Wednesday, April 24, 2024
Acrivon Therapeutics shares are trading highe...
Benzinga Newsdesk
Acrivon Therapeutics Reports A 50% Confirmed ...
Benzinga Newsdesk
Acrivon Therapeutics Reports Initial Positive...
Benzinga Newsdesk
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Wednesday, April 10, 2024
Acrivon Therapeutics Presents Data At AACR An...
Benzinga Newsdesk
Tuesday, April 09, 2024
Crude Oil Down Over 1%; Cognyte Software Shares Plummet
Avi Kapoor
Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Dow Dips 150 Points; Laser Photonics Shares Spike Higher
Avi Kapoor
Acrivon Therapeutics Stock Is Soaring Tuesday: What's Going On?
Adam Eckert
Dow Gains Over 50 Points; Neogen Posts Downbeat Earnings
Avi Kapoor
Market-Moving News for April 9th
Benzinga Newsdesk
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Acrivon Therapeutics shares are trading highe...
Benzinga Newsdesk
Acrivon Therapeutics Announces $130M Private ...
Benzinga Newsdesk
Friday, April 05, 2024
Ladenburg Thalmann Maintains Buy on Acrivon T...
Benzinga Newsdesk
Monday, April 01, 2024
BMO Capital Reiterates Outperform on Acrivon ...
Benzinga Newsdesk
JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk
Thursday, March 28, 2024
HC Wainwright & Co. Reiterates Buy on Acrivon...
Benzinga Newsdesk
Acrivon Therapeutics: Q4 Earnings Insights
Benzinga Insights
Acrivon Therapeutics Q4 EPS $(0.86) Misses $(...
Benzinga Newsdesk
Friday, March 15, 2024
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
Tuesday, March 05, 2024
Acrivon Therapeutics To Present Data At AACR ...
Benzinga Newsdesk
Friday, March 01, 2024
JMP Securities Initiates Coverage On Acrivon ...
Benzinga Newsdesk
Tuesday, December 05, 2023
Why Daktronics Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
Monday, December 04, 2023
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Tuesday, November 28, 2023
Acrivon Therapeutics Announces FDA Has Grante...
Benzinga Newsdesk
Friday, November 10, 2023
Analyst Ratings for Acrivon Therapeutics
Benzinga Insights
BMO Capital Maintains Outperform on Acrivon T...
Benzinga Newsdesk
Thursday, November 09, 2023
Acrivon Therapeutics Q3 EPS $(0.66) Beats $(0...
Benzinga Newsdesk
Recap: Acrivon Therapeutics Q3 Earnings
Benzinga Insights
Monday, October 16, 2023
Acrivon Therapeutics Presents Data Demonstrat...
Benzinga Newsdesk
Thursday, October 05, 2023
Analyst Expectations for Acrivon Therapeutics's Future
Benzinga Insights
Maxim Group Initiates Coverage On Acrivon The...
Benzinga Newsdesk
Wednesday, October 04, 2023
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
Tuesday, September 19, 2023
Acrivon Therapeutics To Highlight Its ACR-368...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch